Status:

COMPLETED

Survival With Patients Treated With Salivary Gland Cancer

Lead Sponsor:

Clinical Center of Vojvodina

Conditions:

Salivary Gland Cancer

Salivary Gland Neoplasms

Eligibility:

All Genders

Brief Summary

Salivary gland malignancies is very heterogenous group of tumors regarding tumor histology and localization. The aim of this study is to assess main clinical and pathological parameters related to pat...

Detailed Description

The retrospective study enrolled medical charts of the patients treated due to salivaly gland cancers in the Clinic for maxillofacial surgery at Clinical center of Vojvodina in the period of 1. Januar...

Eligibility Criteria

Inclusion

  • Patients with salivary gland malignancies treted in the Clinic for maxillofacial surgery

Exclusion

  • Incomplete medical data Patients with metastatic tumord of salivary gland Patients with recurrent malignancies of salivary glands sent from other clinics

Key Trial Info

Start Date :

January 1 2022

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

April 30 2022

Estimated Enrollment :

250 Patients enrolled

Trial Details

Trial ID

NCT05390294

Start Date

January 1 2022

End Date

April 30 2022

Last Update

May 25 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Clinic for maxillofacial surgery Clinical center of Vojvodina

Novi Sad, Serbia, 11000

Survival With Patients Treated With Salivary Gland Cancer | DecenTrialz